2015
A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells, Nicholas Lamparella DO (Article)
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204., Jerome C Landry, Yang Feng, Roshan S Prabhu, Steven J Cohen, Charles A Staley, Richard Whittington, Elin Ruth Sigurdson, Halla Nimeiri, Udit Verma, and Al Bowen Benson (Article)
Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology., Gregory A Masters, Lada Krilov, Howard H Bailey, Marcia S Brose, Harold Burstein, Lisa R Diller, Don S Dizon, Howard A Fine, Gregory P Kalemkerian, Mark Moasser, Michael N Neuss, Steven J O'Day, Olatoyosi Odenike, Charles J Ryan, Richard L Schilsky, Gary K Schwartz, Alan P Venook, Sandra L Wong, and Jyoti D Patel (Article)
Alcohol consumption and prognosis in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance)., Suresh G. Nair MD (Article)
Influence of molecular alterations on site-specific (ss) time to recurrence (TTR) following adjuvant therapy in resected colon cancer (CC) (Alliance Trial N0147)., Suresh G. Nair MD (Article)
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer., B H O'Neil, A J Scott, W W Ma, S J Cohen, D L Aisner, A R Menter, M A Tejani, J K Cho, J Granfortuna, L Coveler, O O Olowokure, J C Baranda, M Cusnir, P Phillip, J Boles, R Nazemzadeh, M Rarick, D J Cohen, J Radford, L Fehrenbacher, R Bajaj, V Bathini, P Fanta, J Berlin, A J McRee, R Maguire, F Wilhelm, M Maniar, A Jimeno, C L Gomes, and W A Messersmith (Article)
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer., B H O'Neil, A J Scott, W W Ma, S J Cohen, L Leichman, D L Aisner, A R Menter, M A Tejani, J K Cho, J Granfortuna, L Coveler, O O Olowokure, J C Baranda, M Cusnir, P Phillip, J Boles, R Nazemzadeh, M Rarick, D J Cohen, J Radford, L Fehrenbacher, R Bajaj, V Bathini, P Fanta, J Berlin, A J McRee, R Maguire, F Wilhelm, M Maniar, A Jimeno, C L Gomes, and W A Messersmith (Article)
Neoadjuvant chemotherapy for primary cutaneous/soft tissue angiosarcoma: Determining tumor behavior prior to surgical resection., Jacqueline Oxenberg DO, Nikhil I Khushalani, Kilian E Salerno, Kristopher Attwood, and John M Kane (Article)
Multidisciplinary cancer conferences for gastrointestinal malignancies result in measureable treatment changes: a prospective study of 149 consecutive patients., Jacqueline Oxenberg DO, Wesley Papenfuss, Iyare Esemuede, Kristopher Attwood, Marko Simunovic, Boris Kuvshinoff, and Valerie Francescutti (Article)
Polo-like kinase and its inhibitors: Ready for the match to start?, Neil D Palmisiano and Margaret T Kasner (Article)
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies., Vincent J Picozzi, Ramesh K Ramanathan, Maeve A Lowery, Allyson J Ocean, Edith P Mitchel, Bert H O'Neil, Michael J Guarino, Paul R Conkling, Steven J Cohen, Nathan Bahary, Richard C Frank, Tomislav Dragovich, Benjamin B Bridges, Fadi S Braiteh, Alexander N Starodub, Fa-Chyi Lee, Thomas E Gribbin, Donald A Richards, Marie Lee, Ronald L Korn, Neeta Pandit-Taskar, Stanley J Goldsmith, Charles M Intenzo, Arif Sheikh, Timothy C Manzone, Heather Horne, Robert M Sharkey, William A Wegener, Eileen M O'Reilly, David M Goldenberg, and Daniel D Von Hoff (Article)
Activity and Safety of Nivolumab, an Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small-Cell Lung Cancer (CheckMate 063): a Phase 2, Single-Arm Trial., Naiyer A. Rizvi, Julien Mazières, David Planchard, Thomas E. Stinchcombe, Grace K. Dy, Scott J. Antonia, Leora Horn MD, Hervé Lena, Elisa Minenza MD, Bertrand Mennecier, Gregory A. Otterson, Luis T. Campos, David R. Gandara, Benjamin P. Levy, Suresh G. Nair MD, Gérard Zalcman, Jürgen Wolf, Pierre-Jean Souquet, Editta Baldini, Federico Cappuzzo, Christos Chouaid, Afshin Dowlati, Rachel Sanborn, Ariel Lopez-Chavez, Christian Grohe, Rudolf M. Huber, Christopher T. Harbison, Christine Baudelet, Brian J. Lestini, and Suresh S. Ramalingam (Article)
Primary Dural Lymphoblastic B-Cell Lymphoma: A Rare Subtype of Aggressive Dural Lymphoma., Christine Saraceni, Nicole M. Agostino DO, and Shereen M. Gheith MD (Article)
Clinical Characteristics and Treatment-Related Biomarkers Associated with Response to High-Dose Interleukin-2 in Metastatic Melanoma and Renal Cell Carcinoma: Retrospective Analysis of an Academic Community Hospital's Experience., Christine Saraceni, Nicole M. Agostino DO, Michael J. Weiss MPH, Kaherine Harris MD, and Suresh G. Nair MD (Article)
Cystic Brain Metastases in NSCLC Harboring the EML4-ALK Translocation after Treatment with Crizotinib., Christine Saraceni; P. Mark Li MD, PhD; Justin F Gainor; Gary A. Stopyra MD; and Eliot L. Friedman MD (Article)
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation., Michael J Satlin; Santosh Vardhana; Rosemary Soave; Tsiporah B Shore; Tomer M Mark; Samantha E Jacobs; Thomas J Walsh; and Usama Gergis MD, MBA (Article)
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer., Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H Shah, Ana O Hoff, Andrew G Gianoukakis, Naomi Kiyota, Matthew H Taylor, Sung-Bae Kim, Monika K Krzyzanowska, Corina E Dutcus, Begoña de las Heras, Junming Zhu, and Steven I Sherman (Article)
Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer., Talha Shaikh, Karen Ruth, Walter J Scott, Barbara A Burtness, Steven J Cohen, Andre A Konski, Harry S Cooper, Igor Astsaturov, and Joshua E Meyer (Article)
Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer., Talha Shaikh, Alan Thomay, Karen Ruth, Steven J Cohen, and Joshua E Meyer (Article)
Relationship Between Metformin Use and Recurrence and Survival in Patients (PTS) with Resected Stage III Colon Cancer (CC) Receiving Adjuvant Chemotherapy: Results from NCCTG N0147 (Alliance)., Preet Paul Singh; Qian Shi; Nathan R. Foster; Axel Grothey; Suresh G. Nair MD; Emely Chan; Anthony F. Shields; Richard M. Goldberg; Morton S. Kahlenberg; Frank A. Sinicrope; Daniel J. Sargent; and Steven R. Alberts MD, MPH (Article)
Discordance of Receptor Status in Breast Cancer Throughout Tumor Progression and the Associated Prognostic Implications: A Case Report and Review of the Literature, Laura Spranklin DO and Ranjit R. Nair MD (Article)
A Case Report of Enteric Duplication Cyst: A Unique Presentation With Multiple Rare Associations, Arsha Sreedhar MD, Ranjit R. Nair MD, and William Scialla DO (Poster)
The Genomic Landscape of Juvenile Myelomonocytic Leukemia., Elliot Stieglitz, Amaro N. Taylor-Weiner, Tiffany Y. Chang, Laura C. Gelston, Yong-Dong Wang, Tali Mazor, Emilio Esquivel, Ariel Yu, Sara Seepo, Scott R. Olsen, Mara Rosenberg, Sophie L. Archambeault, Ghada Abusin, Kyle Beckman, Patrick A. Brown, Michael Briones, Benjamin Carcamo, Todd Cooper, Gary V. Dahl, Peter D. Emanuel, Mark N. Fluchel, Rakesh K. Goyal, Robert J. Hayashi, Johann Hitzler, Christopher Hugge, Y Lucy Liu, Yoav H. Messinger, Donald H. Mahoney, Philip Monteleone MD, Eneida R. Nemecek, Philip A. Roehrs, Reuven J. Schore, Kimo C. Stine, Clifford M. Takemoto, Jeffrey A. Toretsky, Joseph F. Costello, Adam B. Olshen, Chip Stewart, Yongjin Li, Jing Ma, Robert B. Gerbing, Todd A. Alonzo, Gad Getz, Tanja A. Gruber, Todd R. Golub, Kimberly Stegmaier, and Mignon L. Loh (Article)
In The Groove: A Case Series of Groove Pancreatitis, Matthew Sullivan DO, Jeffrey Brodsky MD, Shashin Shah MD, and Hiral N. Shah MD (Poster)
Clinicopathologic correlation and effect of Oncotype DX Recurrence Score on treatment decisions at a community-based academic cancer center., Sameer Tolay MD (Article)
Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin, Amir Toor MD (Article)
Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes., Amir Toor MD, Roy T Sabo, Catherine H Roberts, Bonny L Moore, Salman R Salman, Allison F Scalora, May T Aziz, Ali S Shubar Ali, Charles E Hall, Jeremy Meier, Radhika M Thorn, Elaine Wang, Shiyu Song, Kristin Miller, Kathryn Rizzo, William B Clark, John M McCarty, Harold M Chung, Masoud H Manjili, and Michael C Neale (Article)
On The Organization Of Human T Cell Receptor Loc, Amir Toor MD, Abdullah A. Toor, and Masound H. Manjili (Article)
Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience., Namrata Vijayvergia, Efrat Dotan, Karthik Devarajan, Kamel Hatahet, Farah Rahman, Julianna Ricco, Bianca Lewis, Sameer Gupta, and Steven J Cohen (Article)
Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation., Lora S Wang, Talha Shaikh, Elizabeth A Handorf, John P Hoffman, Steven J Cohen, and Joshua E Meyer (Article)
Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer., Francis Worden, Martin Fassnacht, Yuankai Shi, Tatiana Hadjieva, Françoise Bonichon, Ming Gao, Laura Fugazzola, Yuichi Ando, Yasuhisa Hasegawa, Do Joon Park, Young Kee Shong, Johannes W A Smit, John Chung, Christian Kappeler, Gerold Meinhardt, Martin Schlumberger, and Marcia S Brose (Article)
Common questions about wound care., Brooke Worster, Michelle Q Zawora, and Christine Hsieh (Article)
BRAF mutation and thyroid cancer recurrence., Mark Yarchoan, Virginia A LiVolsi, and Marcia S Brose (Article)
Reply to C. Bal et al and M. Xing., Mark Yarchoan, Virginia A LiVolsi, and Marcia S Brose (Article)
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin., Siqin Ye; Bin Cheng; Gregory Y H Lip MD; Richard Buchsbaum; Ralph L. Sacco MD, MS; Bruce Levin PhD; Marco R. Di Tullio MD; Min Qian PhD; Douglas L. Mann MD; Patrick M. Pullicino MD; Ronald S. Freudenberger MD; John R. Teerlink MD; Jay P. Mohr MD; Susan Graham MD; Arthur J. Labovitz MD; Conrado J. Estol MD, PhD; Dirk J. Lok MD; Piotr Ponikowski MD, PhD; Stefan D. Anker MD, PhD; John L P Thompson PhD; and Shunichi Homma MD (Article)
2014
A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors., Eric Angevin, Josep Tabernero, Elena Elez, Steven J Cohen, Rastilav Bahleda, Jean-Luc van Laethem, Christian Ottensmeier, Jose A Lopez-Martin, Sally Clive, Florence Joly, Isabelle Ray-Coquard, Luc Dirix, Jean-Pascal Machiels, Neil Steven, Manjula Reddy, Brett Hall, Thomas A Puchalski, Rajesh Bandekar, Helgi van de Velde, Brenda Tromp, Jessica Vermeulen, and Razelle Kurzrock (Article)
A phase 3, multicenter, double-blind, placebo-controlled trial of lenvatinib (E7080) in patients with 131I-refractory differentiated thyroid cancer (SELECT)., M Brose (Article)
Molecular predictors of response to sorafenib in patients with radioactive iodine-resistant advanced thyroid cancer, M Brose (Article)
Phase II trial of sorafenib in advanced thyroid cancer: A disease site analysis, M Brose (Article)
Management of sorafenib-related adverse events: a clinician's perspective., Marcia S Brose, Catherine T Frenette, Stephen M Keefe, and Stacey M Stein (Article)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial., Marcia S Brose, Christopher M Nutting, Barbara Jarzab, Rossella Elisei, Salvatore Siena, Lars Bastholt, Christelle de la Fouchardiere, Furio Pacini, Ralf Paschke, Young Kee Shong, Steven I Sherman, Johannes W A Smit, John Chung, Christian Kappeler, Carol Peña, István Molnár, and Martin J Schlumberger (Article)
Comprehensive Analysis of Serum Biomarker and Tumor Gene Mutation Associated with Clinical Outcomes in the Phase 3 Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid (Select), M S. Brose (Article)
Effect of age on the efficacy and safety of lenvatinib for the treatment of 131i-refractory differentiated thyroid cancer in the phase 3 select study, M S. Brose (Article)
Subgroup Analyses of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Trial of Lenvatinib (E7080) in Patients with 131I-Refractory Differentiated Thyroid Cancer, M S. Brose (Article)
Treatment-Emergent Hypertension and Efficacy in the Phase 3 Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid (Select), M S. Brose (Article)
Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation., Jackrapong Bruminhent, Zi-Xuan Wang, Carol Hu, John Wagner, Richard Sunday, Brent Bobik, Sarah Hegarty, Scott Keith, Seyfettin Alpdogan, Matthew Carabasi, Joanne Filicko-O'Hara, Neal Flomenberg, Margaret Kasner, Ubaldo Martinez Outschoorn, Mark Weiss, and Phyllis Flomenberg (Article)
A phase I study of cabozantinib (XL184) in patients with differentiated thyroid cancer., Maria E Cabanillas, Marcia S Brose, Jaymes Holland, Kimberly C Ferguson, and Steven I Sherman (Article)
Neoadjuvant chemoradiation and duration of chemotherapy before surgical resection for pancreatic cancer: does time interval between radiotherapy and surgery matter?, Kathryn T Chen, Karthik Devarajan, Barton N Milestone, Harry S Cooper, Crystal Denlinger, Steven J Cohen, Joshua E Meyer, and John P Hoffman (Article)
Second-line treatment for advanced thyroid cancer: an indication in need of randomized clinical trials., Aaron B Cohen and Marcia S Brose (Article)
Academic (AO) and community (CO) oncologists’ knowledge, understanding, and preparedness for clinical next-generation sequencing genomic testing (NGSGT), S J. Cohen (Article)
Activity of IMMU-130 anti-CEACAM5-SN-38 antibody-drug conjugate (ADC) on metastatic colorectal cancer (mCRC) having relapsed after CPT-11: Phase I study., S J. Cohen (Article)
Adherence to NCCN survivorship guidelines in non-small cell lung cancer (NSCLC) and colorectal cancer (CRC), S J. Cohen (Article)
Cognitive Changes After Surgery in the Elderly: Does Minimally Invasive Surgery Influence the Incidence of Postoperative Cognitive Changes Compared to Open Colon Surgery?, S J. Cohen (Article)
Feasibility and results of a randomized phase Ιb study of fractionated 90Υ-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having two or more prior therapies., S J. Cohen (Article)
Profiling of 1,350 neuroendocrine tumors for identification of multiple potential drug targets, S J. Cohen (Article)
Randomized phase II study of paclitaxel with or without the anti-IGF-IR antibody cixutumumab (IMC-A12) as second-line treatment for patients with metastatic esophageal or GE junction cancer, S J. Cohen (Article)
Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer., S J Cohen, A A Konski, S Putnam, D S Ball, J E Meyer, J Q Yu, I Astsaturov, C Marlow, A Dickens, D N Cade, and N J Meropol (Article)
A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers., Crystal S Denlinger, Neal J Meropol, Tianyu Li, Nancy L Lewis, Paul F Engstrom, Louis M Weiner, Jonathan D Cheng, R Katherine Alpaugh, Harry Cooper, John J Wright, and Steven J Cohen (Article)
Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer., Efrat Dotan, Karthik Devarajan, A James D'Silva, Andrew Beck, Dwight D Kloth, Steven J Cohen, and Crystal Denlinger (Article)
A 2-Step Approach to Haploidentical Versus Matched Related Hematopoietic Stem Cell Transplantation (HSCT): Equivalent Early Immune Reconstitution with Comparable Outcomes, Joanne Filicko (Article)
Autologous Stem Cell Mobilization with Pegfilgrastim and Planned Plerixafor Is Equally Effective and Safer As Compared with Cyclophosphamide, Pegfilgrastim and Plerixafor, Joanne Filicko (Article)
Comparison of Peripheral Blood Vs. Bone Marrow Chimerism after a Reduced Intensity Conditioning Allogeneic Stem Cell Transplant, Joanne Filicko (Article)
Engraftment and Immune Recovery (IR) in Good Risk Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Two Different Approaches Using Cyclophosphamide (CY) for T-Cell Tolerization, Joanne Filicko (Article)
CD3/8 T-Cell Responses to CMV Reactivation in Patients Undergoing Haploidentical Transplants: A Retrospective Analysis, Joanne Filicko-O'Hara (Article)
Clinical Outcomes of 2-Step Approach to Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Effects of CD34 Stem Cell Dose in the Setting of a Consistent T-Cell Dose, Joanne Filicko-O'Hara (Article)
Effect of body mass index on outcomes of autologous hematopoietic stem cell transplantation, Joanne Filicko-O'Hara (Article)
Hematopoietic Cell Transplant Co-Morbidity Index (HCT-CI): Ability to Predict Outcomes in Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT), Joanne Filicko-O'Hara (Article)
Impact of Body Mass Index on Outcomes After Autologous Hematopoietic Stem Cell Transplantation, Joanne Filicko-O'Hara (Article)
Results of a phase I study of bendamustine in combination with ofatumumab, carboplatin, and etoposide (BOCE) for refractory or relapsed aggressive B-cell non-Hodgkin lymphomas (NHL), Joanne Filicko-O'Hara (Article)
Assessing the Development of Multidisciplinary Care: Experience of the National Cancer Institute Community Cancer Centers Program., Eliot L. Friedman MD, Neetu Chawla, Paul T. Morris, Kathleen M. Castro, Angela C. Carrigan, Irene Prabhu Das, and Steven B. Clauser (Article)
Haplo+cord transplantation: Neutrophil and platelet recovery and long-term survival compared to double umbilical cord blood (UCB) transplantation—A case-cohort analysis., Usama Gergis MD, MBA (Article)
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation., Usama Gergis MD, MBA; S Mayer; B Gordon; T Mark; R Pearse; T Shore; and K Van Besien (Article)
Immunoblastic Follicular Lymphoma: A Very Unusual Transformation of Low-Grade Follicular Lymphoma., Shereen M. Gheith MD, Dennis B. Cornfield, Weiyi Chen, Pal Singh-Kahlon, and Basil Ahmed MD (Article)
Patient and Tumor Characteristics and BRAF and KRAS Mutations in ColonCancer, NCCTG/Alliance N0147., Wilson I. Gonsalves; Michelle R. Mahoney; Daniel J. Sargent; Garth D. Nelson; Steven R. Alberts MD, MPH; Frank A. Sinicrope; Richard M. Goldberg; Paul J. Limburg; Stephen N. Thibodeau; Axel Grothey; Joleen M. Hubbard; Emily Chan; Suresh G. Nair MD; Jeffrey L. Berenberg; and Robert R. McWilliams (Article)
The Evolving Treatment Landscape for Metastatic Differentiated Thyroid Cancer., Carolyn Grande and Marcia S Brose (Article)
Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature., Housam Haddad; Suchitra Sundaram; Cynthia Magro; and Usama Gergis MD, MBA (Article)
Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147, Jocelin Huang; Suresh G. Nair MD; Michelle R. Mahoney; Garth D. Nelson; Anthony F. Shields; Emily Chan; Richard M. Goldberg; Sharlene Gill; Morton S. Kahlenberg; James T. Quesenberry; Stephen N. Thibodeau; Thomas C. Smyrk; Axel Grothey; Frank A. Sinicrope; Thomas A. Webb; Gist H. Farr; Barbara A. Pockaj; Jeffrey L. Berenberg; Margaret Mooney; Daniel J. Sargent; and Steven R. Alberts MD, MPH (Article)
In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation., Max Jameson-Lee, Vishal Koparde, Phil Griffith, Allison F Scalora, Juliana K Sampson, Haniya Khalid, Nihar U Sheth, Michael Batalo, Myrna G Serrano, Catherine H Roberts, Michael L Hess, Gregory A Buck, Michael C Neale, Masoud H Manjili, and Amir Toor MD (Article)
Clinical Outcomes of 2-Step Approach to Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Effects of CD34 Stem Cell Dose in the Setting of a Consistent T-Cell Dose, M Kasner (Article)
Phase 1/1b Study of RG7388, a Potent MDM2 Antagonist, in Acute Myelogenous Leukemia (AML) Patients (Pts), M Kasner (Article)
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer., Andre Konski, Joshua E Meyer, Michael Joiner, Michael J Hall, Philip Philip, Anthony Shields, Erin McSpadden, Minsig Choi, Beth Adaire, Gail Duncan, Neal J Meropol, Terrence P Cescon, and Steven J Cohen (Article)
Etiology of GVHD: alloreactivity or impaired cellular adaptation?, Masoud H Manjili and Amir Toor MD (Article)
Ectopic Cushing Syndrome and Pancreatic Cancer: A Case Report, Mira Mitry MD; Nicole M. Agostino DO; Stacey Smith MD, FACP; and Vasudev G. Magaji MD, MS (Poster)
A rare case of acute lymphoblastic leukemia in a patient with light chain (AL) amyloidosis treated with lenalidomide., Ranjit R. Nair MD; Shereen M F Gheith MD, PhD; Dan Popescu; and Nicole M. Agostino DO (Article)
Miss the Ear, and You May Miss the Diagnosis, Ranjit R. Nair MD and Yehia Y. Mishriki MD (Article)
Cutaneous lymphocyte antigen expression loss and PD1 positivity in early cutaneous lesions of rapidly progressive mycosis fungoides., Olakunle Ogunrinade; Christine S Ahn; Usama Gergis MD, MBA; Aminah H Yassin; and Cynthia Magro (Article)
Ablative therapies for colorectal polyps and malignancy., Jacqueline Oxenberg DO, Steven N Hochwald, and Steven Nurkin (Article)
The role of radiation therapy in melanoma., Jacqueline Oxenberg DO and John M Kane (Article)
Impact of preoperative therapy on patterns of recurrence in pancreatic cancer., Pavlos Papavasiliou, John P Hoffman, Steven J Cohen, Joshua E Meyer, James C Watson, and Yun Shin Chun (Article)
Morbidity and mortality associated with gastrectomy for gastric cancer., Wesley A Papenfuss, Moshim Kukar, Jacqueline Oxenberg DO, Kristopher Attwood, Steven Nurkin, Usha Malhotra, and Neal W Wilkinson (Article)
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology., Jyoti D Patel, Lada Krilov, Sylvia Adams, Carol Aghajanian, Ethan Basch, Marcia S Brose, William L Carroll, Marcos de Lima, Mark R Gilbert, Mark G Kris, John L Marshall, Gregory A Masters, Steven J O'Day, Blasé Polite, Gary K Schwartz, Sunil Sharma, Ian Thompson, Nicholas J Vogelzang, and Bruce J Roth (Article)
Successful imatinib therapy for neuroendocrine carcinoma with activating Kit mutation: a case study., James Perkins, Patrick Boland, Steven J Cohen, Anthony J Olszanski, Yan Zhou, Paul Engstrom, and Igor Astsaturov (Article)
Phase II Study of Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer: Metastatic Non-small Cell Lung Cancer, S S. Ramalingam, J Mazieres, D Planchard, T E. Stinchcombe, G K. Dy, S J. Antonia, L Horn, H Lena, E Minenza, B Mennecier, G A. Otterson, L T. Campos, D R. Gandara, B P. Levy, Suresh G. Nair MD, G Zalcman, J Wolf, C Baudelet, B J. Lestini, and N A. Rizvi (Article)
Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions., Marsha Reyngold, Joyce Niland, Anna ter Veer, Dana Milne, Tanios Bekaii-Saab, Steven J Cohen, Lily Lai, Deborah Schrag, John M Skibber, William Small, Martin Weiser, Neal Wilkinson, and Karyn A Goodman (Article)
Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation., Juliana K Sampson, Nihar U Sheth, Vishal N Koparde, Allison F Scalora, Myrna G Serrano, Vladimir Lee, Catherine H Roberts, Max Jameson-Lee, Andrea Ferreira-Gonzalez, Masoud H Manjili, Gregory A Buck, Michael C Neale, and Amir Toor MD (Article)
Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors., P V Sanchez, S T Glantz, S Scotland, M T Kasner, and M Carroll (Article)
Definition and management of radioactive iodine-refractory differentiated thyroid cancer., Martin Schlumberger, Marcia Brose, Rosella Elisei, Sophie Leboulleux, Markus Luster, Fabian Pitoia, and Furio Pacini (Article)